VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 70 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,278,532 | -74.6% | 294,004 | -62.5% | 0.00% | -100.0% |
| Q2 2023 | $8,966,151 | +316.6% | 783,070 | +180.5% | 0.00% | – |
| Q1 2023 | $2,152,379 | +32.0% | 279,167 | +4.5% | 0.00% | – |
| Q4 2022 | $1,630,243 | -20.7% | 267,253 | -23.1% | 0.00% | – |
| Q3 2022 | $2,057,000 | +173.2% | 347,453 | +172.7% | 0.00% | – |
| Q2 2022 | $753,000 | -34.6% | 127,432 | -15.7% | 0.00% | – |
| Q1 2022 | $1,151,000 | +1.2% | 151,202 | -64.0% | 0.00% | – |
| Q4 2021 | $1,137,000 | -29.9% | 419,810 | -32.0% | 0.00% | – |
| Q3 2021 | $1,622,000 | -46.6% | 616,988 | -16.0% | 0.00% | – |
| Q2 2021 | $3,035,000 | +39.1% | 734,609 | +58.6% | 0.00% | – |
| Q1 2021 | $2,182,000 | -57.4% | 463,278 | -35.3% | 0.00% | -100.0% |
| Q4 2020 | $5,121,000 | +1384.3% | 716,333 | +2116.0% | 0.00% | – |
| Q3 2020 | $345,000 | -38.1% | 32,325 | -26.6% | 0.00% | – |
| Q2 2020 | $557,000 | +82.0% | 44,069 | +31.8% | 0.00% | – |
| Q1 2020 | $306,000 | -87.9% | 33,429 | -81.6% | 0.00% | -100.0% |
| Q4 2019 | $2,536,000 | -36.3% | 181,703 | -21.5% | 0.00% | 0.0% |
| Q3 2019 | $3,983,000 | +781.2% | 231,522 | +1294.2% | 0.00% | – |
| Q2 2019 | $452,000 | +11.9% | 16,606 | -21.4% | 0.00% | – |
| Q1 2019 | $404,000 | -63.3% | 21,122 | -81.9% | 0.00% | – |
| Q4 2018 | $1,100,000 | -83.9% | 117,018 | -67.6% | 0.00% | -100.0% |
| Q3 2018 | $6,826,000 | -23.2% | 360,793 | -20.7% | 0.00% | 0.0% |
| Q2 2018 | $8,885,000 | +1.4% | 454,719 | -2.5% | 0.00% | 0.0% |
| Q1 2018 | $8,763,000 | +206.5% | 466,361 | +170.7% | 0.00% | +100.0% |
| Q4 2017 | $2,859,000 | +346.7% | 172,261 | +453.6% | 0.00% | – |
| Q3 2017 | $640,000 | +466.4% | 31,117 | +146.0% | 0.00% | – |
| Q2 2017 | $113,000 | -81.8% | 12,647 | -73.1% | 0.00% | – |
| Q1 2017 | $622,000 | -38.4% | 47,032 | -40.7% | 0.00% | – |
| Q4 2016 | $1,010,000 | +3784.6% | 79,270 | +3588.7% | 0.00% | – |
| Q3 2016 | $26,000 | +2500.0% | 2,149 | +2049.0% | 0.00% | – |
| Q2 2016 | $1,000 | -85.7% | 100 | -88.0% | 0.00% | – |
| Q1 2016 | $7,000 | +133.3% | 832 | +576.4% | 0.00% | – |
| Q4 2015 | $3,000 | – | 123 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $45,697,000 | 3.92% |
| ARMISTICE CAPITAL, LLC | 3,392,000 | $24,253,000 | 0.82% |
| Bellevue Group AG | 2,712,083 | $19,391,000 | 0.22% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 141,924 | $1,015,000 | 0.17% |
| XTX MARKETS LLC | 10,578 | $76,000 | 0.16% |
| Aevitas Wealth Management, Inc. | 22,150 | $158,000 | 0.12% |
| Virtus ETF Advisers LLC | 35,079 | $251,000 | 0.10% |
| HITE Hedge Asset Management LLC | 29,357 | $210,000 | 0.05% |
| LINCOLN CAPITAL CORP | 10,000 | $72,000 | 0.05% |
| CIM INVESTMENT MANAGEMENT INC | 18,745 | $134,000 | 0.04% |